ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-5B15818
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global and India ICAD Intracranial Atherosclerotic Disease Pathology Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report & Forecast 2023-2029

Code: QYRE-Auto-5B15818
Report
November 2023
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ICAD
PTA
Stryker
Balt
Terumo
MicroPort
Acandis GmbH

and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size

The global ICAD (Intracranial Atherosclerotic Disease) Pathology revenue was US$ 174 million in 2022 and is forecast to a readjusted size of US$ 316.2 million by 2029 with a CAGR of 8.8% during the forecast period (2023-2029).

and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market

and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market

Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Stenosis (narrowing) of the artery walls in intracranial atherosclerotic disease (ICAD) develops similarly to atherosclerosis of the heart: from the buildup of plaque, also known as an atherosclerotic lesion. The product in this report is Stent and PTA balloon for Treatment of ICAD.
In India, the ICAD (Intracranial Atherosclerotic Disease) Pathology revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global ICAD (Intracranial Atherosclerotic Disease) Pathology key players include Stryker, Balt, TERUMO, MicroPort, Acandis, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest market, with a share about 45%, followed by North America, with a share about 25 percent. In terms of product, Stent is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
This report focuses on global and India ICAD (Intracranial Atherosclerotic Disease) Pathology market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for ICAD (Intracranial Atherosclerotic Disease) Pathology will continue to grow rapidly in the future.
Global ICAD (Intracranial Atherosclerotic Disease) Pathology Scope and Market Size
ICAD (Intracranial Atherosclerotic Disease) Pathology market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global ICAD (Intracranial Atherosclerotic Disease) Pathology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Report

Report Metric Details
Report Name and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market
Forecasted market size in 2029 US$ 316.2 million
CAGR 8.8%
Forecasted years 2023 - 2029
Segment by Type
  • Stent
  • PTA Balloon
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Stryker, Balt, TERUMO, MicroPort, Acandis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market size in 2029?

Ans: The and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market size in 2029 will be US$ 316.2 million.

What is the market share of major companies in and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market?

Ans: Global top five manufacturers hold a share about 90%.

What is the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market share by type?

Ans: In terms of product, Stent is the largest segment, with a share about 80%.

What is the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The main players in the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market are Stryker, Balt, TERUMO, MicroPort, Acandis

What are the Application segmentation covered in the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The Applications covered in the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market report?

Ans: The Types covered in the and India ICAD (Intracranial Atherosclerotic Disease) Pathology Market report are Stent, PTA Balloon

1 Study Coverage
1.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Product Introduction
1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Outlook 2018 VS 2022 VS 2029
1.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in US$ Million for the Year 2018-2029
1.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume for the Year 2018-2029
1.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Outlook 2018 VS 2022 VS 2029
1.3.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in US$ Million for the Year 2018-2029
1.3.2 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume for the Year 2018-2029
1.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India ICAD (Intracranial Atherosclerotic Disease) Pathology in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Dynamics
1.5.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Trends
1.5.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
1.5.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
1.5.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 ICAD (Intracranial Atherosclerotic Disease) Pathology by Type
2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Type
2.1.1 Stent
2.1.2 PTA Balloon
2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
2.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Type
2.3.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 ICAD (Intracranial Atherosclerotic Disease) Pathology by Application
3.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Other
3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
3.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Application
3.3.1 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Competitor Landscape by Company
4.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Company
4.1.1 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Ranked by Revenue (2022)
4.1.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturer (2018-2023)
4.1.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturer (2018-2023)
4.1.4 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturer (2018-2023)
4.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Concentration Ratio (CR)
4.2.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology in 2022
4.2.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Product Offered and Application
4.5 Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Company
4.7.1 Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology in India, Ranked by Revenue (2022)
4.7.2 India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Players (2018-2023)
4.7.3 India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Players (2018-2023)
5 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region
5.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size in Volume by Region (2018-2029)
5.2.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region: 2018-2023
5.2.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume Forecast by Region (2024-2029)
5.3 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size in Value by Region (2018-2029)
5.3.1 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region: 2018-2023
5.3.2 Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2018-2029
6.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2018-2029
7.2 EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2018-2029
8.2 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size YoY Growth 2018-2029
9.2 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Stryker
10.1.1 Stryker Company Information
10.1.2 Stryker Description and Business Overview
10.1.3 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
10.1.5 Stryker Recent Development
10.2 Balt
10.2.1 Balt Company Information
10.2.2 Balt Description and Business Overview
10.2.3 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
10.2.5 Balt Recent Development
10.3 TERUMO
10.3.1 TERUMO Company Information
10.3.2 TERUMO Description and Business Overview
10.3.3 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
10.3.4 TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
10.3.5 TERUMO Recent Development
10.4 MicroPort
10.4.1 MicroPort Company Information
10.4.2 MicroPort Description and Business Overview
10.4.3 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
10.4.4 MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
10.4.5 MicroPort Recent Development
10.5 Acandis
10.5.1 Acandis Company Information
10.5.2 Acandis Description and Business Overview
10.5.3 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Products Offered
10.5.5 Acandis Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Industry Chain Analysis
11.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 ICAD (Intracranial Atherosclerotic Disease) Pathology Production Mode & Process
11.4 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales and Marketing
11.4.1 ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Channels
11.4.2 ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors
11.5 ICAD (Intracranial Atherosclerotic Disease) Pathology Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
ICAD
PTA
Stryker
Balt
Terumo
MicroPort
Acandis GmbH
List of Tables
    Table 1. ICAD (Intracranial Atherosclerotic Disease) Pathology CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Trends
    Table 3. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Drivers
    Table 4. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Challenges
    Table 5. ICAD (Intracranial Atherosclerotic Disease) Pathology Market Restraints
    Table 6. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Manufacturer, 2018-2023
    Table 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Manufacturer, (Units), 2018-2023
    Table 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Manufacturer, 2018-2023
    Table 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICAD (Intracranial Atherosclerotic Disease) Pathology as of 2022)
    Table 18. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Product Offered and Application
    Table 20. Global Key Manufacturers of ICAD (Intracranial Atherosclerotic Disease) Pathology, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of ICAD (Intracranial Atherosclerotic Disease) Pathology in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Share by Players, (2018-2023)
    Table 25. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Players, (Units), (2018-2023)
    Table 26. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Share by Players, (2018-2023)
    Table 27. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Region (2018-2023) & (Units)
    Table 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume Forecast by Region (2024-2029) & (Units)
    Table 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018-2023) & (Units)
    Table 36. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2024-2029) & (Units)
    Table 37. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018-2023) & (Units)
    Table 41. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2024-2029) & (Units)
    Table 42. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2018-2023) & (Units)
    Table 46. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume by Country (2024-2029) & (Units)
    Table 47. Stryker Company Information
    Table 48. Stryker Description and Business Overview
    Table 49. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 50. Stryker ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 51. Stryker Recent Development
    Table 52. Balt Company Information
    Table 53. Balt Description and Business Overview
    Table 54. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 55. Balt ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 56. Balt Recent Development
    Table 57. TERUMO Company Information
    Table 58. TERUMO Description and Business Overview
    Table 59. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 60. TERUMO ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 61. TERUMO Recent Development
    Table 62. MicroPort Company Information
    Table 63. MicroPort Description and Business Overview
    Table 64. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 65. MicroPort ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 66. MicroPort Recent Development
    Table 67. Acandis Company Information
    Table 68. Acandis Description and Business Overview
    Table 69. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 70. Acandis ICAD (Intracranial Atherosclerotic Disease) Pathology Product
    Table 71. Acandis Recent Development
    Table 72. Key Raw Materials Lists
    Table 73. Raw Materials Key Suppliers Lists
    Table 74. ICAD (Intracranial Atherosclerotic Disease) Pathology Customers List
    Table 75. ICAD (Intracranial Atherosclerotic Disease) Pathology Distributors List
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. ICAD (Intracranial Atherosclerotic Disease) Pathology Product Picture
    Figure 2. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size 2018-2029 (US$ Million)
    Figure 4. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2018-2029 (Units)
    Figure 5. India ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Size 2018-2029 (US$ Million)
    Figure 7. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales 2018-2029 (Units)
    Figure 8. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share in Global, in Volume (Units) 2018-2029
    Figure 10. ICAD (Intracranial Atherosclerotic Disease) Pathology Report Years Considered
    Figure 11. Product Picture of Stent
    Figure 12. Product Picture of PTA Balloon
    Figure 13. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type in 2022 & 2029
    Figure 14. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 15. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2018-2029)
    Figure 16. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2029) & (Units)
    Figure 17. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2018-2029)
    Figure 18. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2018-2029) & (USD/Unit)
    Figure 19. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Type in 2022 & 2029
    Figure 20. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 21. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Type (2018-2029)
    Figure 22. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2029) & (Units)
    Figure 23. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2018-2029)
    Figure 24. India ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Type (2018-2029) & (USD/Unit)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Clinic
    Figure 27. Product Picture of Other
    Figure 28. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application in 2022 & 2029
    Figure 29. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 30. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2018-2029)
    Figure 31. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2029) & (Units)
    Figure 32. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2018-2029)
    Figure 33. Global ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2018-2029) & (USD/Unit)
    Figure 34. India ICAD (Intracranial Atherosclerotic Disease) Pathology Market Share by Application in 2022 & 2029
    Figure 35. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 36. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Value by Application (2018-2029)
    Figure 37. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2029) & (Units)
    Figure 38. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2018-2029)
    Figure 39. India ICAD (Intracranial Atherosclerotic Disease) Pathology Price by Application (2018-2029) & (USD/Unit)
    Figure 40. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume Growth Rate 2018-2029 (Units)
    Figure 41. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 42. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2029) & (Units)
    Figure 43. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2018-2029)
    Figure 44. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2029) & (Units)
    Figure 45. Americas ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2018-2029)
    Figure 46. United States ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Canada ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Mexico ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume Growth Rate 2018-2029 (Units)
    Figure 51. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 52. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2029) & (Units)
    Figure 53. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2018-2029)
    Figure 54. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2029) & (Units)
    Figure 55. EMEA ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2018-2029)
    Figure 56. Europe ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Middle East ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Africa ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume Growth Rate 2018-2029 (Units)
    Figure 60. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 61. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2029) & (Units)
    Figure 62. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2018-2029)
    Figure 63. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2029) & (Units)
    Figure 64. China ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2018-2029)
    Figure 65. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Volume Growth Rate 2018-2029 (Units)
    Figure 66. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 67. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Type (2018-2029) & (Units)
    Figure 68. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Type (2018-2029)
    Figure 69. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales by Application (2018-2029) & (Units)
    Figure 70. APAC ICAD (Intracranial Atherosclerotic Disease) Pathology Sales Market Share in Volume by Application (2018-2029)
    Figure 71. Japan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 72. South Korea ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. China Taiwan ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. Southeast Asia ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. India ICAD (Intracranial Atherosclerotic Disease) Pathology Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. ICAD (Intracranial Atherosclerotic Disease) Pathology Value Chain
    Figure 77. ICAD (Intracranial Atherosclerotic Disease) Pathology Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22I19939
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38W19812
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-39V16824
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions